SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Radhakrishnan Srikanth

(Last)

(First)

(Middle)

C/O PULMONX CORPORATION

700 CHESAPEAKE DRIVE

(Street)

REDWOOD CITY

94063

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/03/2025

3. Issuer Name and Ticker or Trading Symbol
Pulmonx Corp [ LUNG ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Science &Techn. Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	181,219⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	⁽²⁾	06/24/2030	Common Stock	1,383⁽³⁾	$1.4	D
Employee Stock Option (right to buy)	⁽²⁾	08/27/2030	Common Stock	20,624⁽³⁾	$2.2	D
Employee Stock Option (right to buy)	⁽²⁾	05/31/2031	Common Stock	26,600	$43.4	D
Employee Stock Option (right to buy)	⁽⁴⁾	02/28/2032	Common Stock	43,000	$26.56	D
Employee Stock Option (right to buy)	⁽⁵⁾	02/28/2033	Common Stock	54,000	$11.48	D
Employee Stock Option (right to buy)	⁽⁶⁾	02/28/2034	Common Stock	31,600	$9.3	D

Explanation of Responses:

1. Includes 149,227 shares of the Issuer's common stock underlying Restricted Stock Units payable solely in common stock of the Issuer.

2. Fully vested.

3. The number of shares reported reflects the shares remaining outstanding as of December 3, 2025 under this option grant.

4. The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2022.

5. The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2023.

6. The shares subject to this option vest in equal monthly installments over the four-year period from the grant date of March 1, 2024.

	/s/ David Aaron Lehman, Attorney-in-Fact	12/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.